Cargando…

VEGF-D: a novel biomarker for detection of COVID-19 progression

Detalles Bibliográficos
Autores principales:	Kong, Yaxian, Han, Junyan, Wu, Xueying, Zeng, Hui, Liu, Jingyuan, Zhang, Henghui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7309201/ https://www.ncbi.nlm.nih.gov/pubmed/32576222 http://dx.doi.org/10.1186/s13054-020-03079-y

Ejemplares similares

Storm of soluble immune checkpoints associated with disease severity of COVID-19
por: Kong, Yaxian, et al.
Publicado: (2020)

Persistent High Percentage of HLA-DR(+)CD38(high) CD8(+) T Cells Associated With Immune Disorder and Disease Severity of COVID-19
por: Du, Juan, et al.
Publicado: (2021)

Soluble Immune-Related Proteins as New Candidate Serum Biomarkers for the Diagnosis and Progression of Lymphangioleiomyomatosis
por: Liu, Xuefei, et al.
Publicado: (2022)

IL-6 may be a good biomarker for earlier detection of COVID-19 progression
por: Wang, Changsong, et al.
Publicado: (2020)

Survivin and VEGF as Novel Biomarkers in Diagnosis of Endometriosis
por: Acimovic, Milena, et al.
Publicado: (2016)

Distinct durability of IgM/IgG antibody responses in COVID-19 patients with differing severity
por: Han, Junyan, et al.
Publicado: (2021)

COVID-19 instigates adipose browning and atrophy through VEGF in small mammals
por: Jing, Xu, et al.
Publicado: (2022)

Novel potential metabolic biomarker panel for early detection of severe COVID-19 using full-spectrum metabolome and whole-transcriptome analyses
por: Li, Zhi-Bin, et al.
Publicado: (2022)

Single cell transcriptome revealed tumor associated antigen (TAA) profile in lung adenocarcinoma (LUAD)
por: Lv, Fang, et al.
Publicado: (2021)

IGHG1 promotes malignant progression in breast cancer cells through the regulation of AKT and VEGF signaling
por: Zhang, Yong, et al.
Publicado: (2023)

Blood platelets and serum VEGF in cancer patients
Publicado: (1999)

Gastric Cancer and Angiogenesis: Is VEGF a Useful Biomarker to Assess Progression and Remission?
por: Macedo, Filipa, et al.
Publicado: (2017)

PDK1/mTOR Signaling in Myeloid Cells Differentially Regulates the Early and Late Stages of Sepsis
por: Du, Juan, et al.
Publicado: (2020)

Immune Effective Score as a Predictor of Response to Neoadjuvant Trastuzumab Therapy and a Prognostic Indicator for HER2-Positive Breast Cancer
por: Wu, Xueying, et al.
Publicado: (2022)

A novel strategy for identifying biomarker in serum of patient with COVID-19 using immune complex
por: Duan, Fugang, et al.
Publicado: (2022)

Interleukin-6 as a potential biomarker of COVID-19 progression
por: Ulhaq, Zulvikar Syambani, et al.
Publicado: (2020)

The role of VEGF in melanoma progression
por: Rajabi, Parvin, et al.
Publicado: (2012)

Curcumin inhibits the lymphangiogenesis of gastric cancer cells by inhibiton of HMGB1/VEGF-D signaling
por: Da, Wei, et al.
Publicado: (2019)

Potential Biomarkers for Defining the Severity, Progression, and Survival from COVID-19
por: Okechukwu, Chidiebere Emmanuel
Publicado: (2021)

Double-stranded DNA in exosomes: a novel biomarker in cancer detection
por: Thakur, Basant Kumar, et al.
Publicado: (2014)

A Fluorescent Aptasensor Based on Assembled G-Quadruplex and Thioflavin T for the Detection of Biomarker VEGF165
por: Zheng, Xin, et al.
Publicado: (2021)

KLK3/PSA and cathepsin D activate VEGF-C and VEGF-D
por: Jha, Sawan Kumar, et al.
Publicado: (2019)

Does anti-VEGF bevacizumab improve survival in experimental sepsis?
por: Besnier, Emmanuel, et al.
Publicado: (2017)

Platelets and VEGF blood levels in cancer patients
por: Gunsilius, E, et al.
Publicado: (1999)

Biosensors based detection of novel biomarkers associated with COVID-19: Current progress and future promise
por: Pal, Mintu, et al.
Publicado: (2022)

Linking COVID-19, monocyte activation and sepsis: MDW, a novel biomarker from cytometry
por: Riva, Giovanni, et al.
Publicado: (2021)

Plasmin Activates the Lymphangiogenic Growth Factors VEGF-C and VEGF-D
por: McColl, Bradley K., et al.
Publicado: (2003)

Trans‐omic analyses identified novel prognostic biomarkers for colorectal cancer survival
por: Liu, Chanjuan, et al.
Publicado: (2023)

Rapamycin reduces primary effusion lymphoma progression by targeting VEGF production and VEGF responses
por: Gasperini, P, et al.
Publicado: (2009)

Biomarkers of angiogenesis and their role in the development of VEGF inhibitors
por: Murukesh, N, et al.
Publicado: (2010)

Biomarkers as Predictive Factors of Anti-VEGF Response
por: Bobadilla, Miriam, et al.
Publicado: (2022)

Evaluating the SERCA2 and VEGF mRNAs as Potential Molecular Biomarkers of the Onset and Progression in Huntington’s Disease
por: Cesca, Federica, et al.
Publicado: (2015)

Observation of total VEGF level in hyperglycemic mouse eyes after intravitreal injection of the novel anti-VEGF drug conbercept
por: Du, Liping, et al.
Publicado: (2015)

Critical Factors for In Vivo Measurements of Human Skin by Terahertz Attenuated Total Reflection Spectroscopy
por: Wang, Lixia, et al.
Publicado: (2020)

Peritumoural neutrophils negatively regulate adaptive immunity via the PD-L1/PD-1 signalling pathway in hepatocellular carcinoma
por: He, Gaixia, et al.
Publicado: (2015)

Communicating with patients requiring anti-VEGF intravitreal injections and their families during the COVID-19 pandemic: an update
por: Korobelnik, Jean-François, et al.
Publicado: (2021)

CircRNA microarray profiling identifies a novel circulating biomarker for detection of gastric cancer
por: Tang, Weiwei, et al.
Publicado: (2018)

Novel VEGF Decoy Receptor Fusion Protein Conbercept Targeting Multiple VEGF Isoforms Provide Remarkable Anti-Angiogenesis Effect In Vivo
por: Wang, Qin, et al.
Publicado: (2013)

Predictive significance of Charcot‐Leyden crystal structures for nasal polyp recurrence
por: Chen, Wenyi, et al.
Publicado: (2022)

Multiple aetiologies of the progressive dysexecutive syndrome and the importance of biomarkers
por: Jones, David T
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_imf68c0ii9q3edck75jhtfn227